Resources
Method development for nitrosamine impurities
Retention chemistry, deuterated internal standards and blank contamination control for nitrosamine methods, with a worked conversion from acceptable intake to working concentration.
Published 25 September 2026 · ImpurityLab technical team
Why these compounds are awkward
Small dialkyl nitrosamines are not difficult to ionise. They are difficult to keep in the instrument long enough to measure.
Consider the size. NDMA has a molecular weight of 74.08 and a computed log P close to zero. It has no useful ultraviolet chromophore, it is volatile, and it is fully miscible with water. Put that on a conventional C18 gradient starting at five or ten percent organic and the compound elutes in the void volume, together with every other polar component of the sample and together with whatever the mobile phase brought with it.
Three consequences follow, and they drive the entire method design:
- There is no useful UV detection. Nitrosamines have a weak n → π* transition in the low ultraviolet, in a region where almost any pharmaceutical matrix absorbs far more strongly. Detection is mass spectrometry, or a nitrogen-specific detector.
- Retention has to be engineered. Either the column chemistry changes, or the analyte does.
- Blank cleanliness sets the limit of detection. At the concentrations involved, the instrument is rarely the limiting factor. The lab is.
Choosing a detection strategy
There are two families of approach, and the choice is usually made for you by the instrument inventory rather than by preference.
| Approach | Strength | Practical constraint |
|---|---|---|
| LC-MS/MS with APCI | Good sensitivity for small polar nitrosamines; less matrix suppression than electrospray in many API matrices | Requires retention chemistry that holds a very polar analyte |
| LC-MS/MS with ESI | Widely available; works for larger, more lipophilic nitrosamines and for nitrosamine drug substance-related impurities | Poor response for the smallest nitrosamines; matrix effects need control |
| GC-MS/MS | Excellent for volatile dialkyl nitrosamines; headspace or direct injection; strong chromatographic retention | Not applicable to non-volatile or thermally labile members of the panel |
| GC with nitrogen chemiluminescence | Selective for the N–NO group; historically the pharmacopoeial approach | Specialised detector; limited throughput |
| High-resolution MS | Confirms elemental composition; useful for nitrosamine drug substance-related impurities | Higher cost per sample; sensitivity for the smallest analytes still depends on retention |
In practice most laboratories run a small-nitrosamine panel on one platform and larger nitrosamine drug substance-related impurities on another, because the two analyte groups have genuinely different physical behaviour.
Retention: change the column, or change the analyte
Because the small nitrosamines sit in a polarity range that reversed-phase does not retain, method development usually takes one of three routes.
- Retain with a different stationary phase. Mixed-mode and graphitic carbon phases both retain small polar analytes that C18 will not. Graphitic carbon in particular gives useful retention for the dialkyl nitrosamines with water-rich mobile phases.
- Start the gradient at pure aqueous. A gradient that begins at one hundred percent aqueous holds the analyte long enough to move it away from the injection front. This works only with a stationary phase that tolerates it.
- Derivatise. Chemical modification increases molecular weight and lipophilicity, moving the analyte into a range where conventional reversed-phase behaves normally. The trade-off is additional sample handling, additional validation, and additional opportunities for loss.
Whichever route is taken, the useful confirmations are the same: the analyte must be resolved from the solvent front, and the retention time must be stable enough that the analyte is not co-eluting with a matrix component whose identity changes between lots.
Choice of internal standard
Isotope-labelled analogues are not optional here. The reasons are specific to this analysis:
- Recovery from the extraction or dilution step varies between samples, and the analyte concentration is low enough that this variation is a large fraction of the signal.
- Ionisation efficiency in the source changes with matrix load, and the matrix load changes with the API lot.
- Any loss during evaporation, filtration or transfer is invisible without a matched internal standard.
The labelled standard should be matched to the analyte — for example a deuterated analogue of the same nitrosamine — and the isotope pattern must not overlap the analyte's own isotope envelope. For deuterium-labelled compounds, check both the isotopic enrichment and the position of labelling, because deuterium on a position that can exchange will not survive the method.
A single deuterated nitrosamine used as the internal standard for an entire panel is a common economy that costs sensitivity. Response factors across the panel differ by more than an order of magnitude, so a matched labelled standard per analyte is what makes the panel quantitative rather than qualitative.
The blank is usually the problem
Nitrosamines are genuinely everywhere. This is the point where method development stops being chromatography and becomes lab discipline.
| Source | What it does | Control |
|---|---|---|
| Gloves and rubber components | Rubber accelerators and amine residues are nitrosamine precursors | Restrict glove types; avoid rubber septa and tubing in the flow path |
| Reagents and solvents | Trace dimethylamine and nitrite in amide solvents and in water | Reserve a solvent lot for this method; test it before use |
| Water purification | Ion-exchange resins and their biofilms can contribute amine precursors | Freshly drawn water; blank the system at the point of use |
| Ambient air and surfaces | Background from the laboratory itself | Dedicated glassware, sealed preparation, minimal open-vessel time |
| Carry-over | High-concentration standards contaminating the following injections | Blank injections between standards; wash cycles validated at the top of the range |
The diagnostic move is simple and it is skipped constantly: inject the mobile phase, inject the extraction blank, and inject a solvent blank from a freshly opened container, in that order, before touching a sample. If the peak is already there, no amount of method optimisation will remove it.
Translating the limit into a working concentration
The acceptable intake is expressed per day. What your method has to detect is expressed per gram of API, and the conversion depends on the maximum daily dose.
Divide the acceptable intake by the maximum daily dose to get the specification in parts per million, then apply the usual factor for a limit test — typically a target at or below thirty percent of the specification — to get the working concentration for the standard curve.
| Step | Worked example |
|---|---|
| Acceptable intake | 96 ng per day — illustrative value only, always take the current assigned value for your specific nitrosamine |
| Maximum daily dose | 2,000 mg per day |
| Specification in the API | 0.048 ppm |
| Working target at 30 percent | 0.014 ppm, or 14 ng per gram of API |
| Concentration in a 50 mg mL−1 sample solution | 0.7 ng mL−1 |
Note what the arithmetic produces. A working concentration below one nanogram per millilitre in a concentrated sample solution is routine for this analysis, and it is exactly the concentration at which a contaminated blank becomes indistinguishable from a real result.
Acceptable intake values are compound-specific and are revised as new potency data arrive. The arithmetic above is illustrative; take the currently assigned value for the specific nitrosamine and the actual maximum daily dose of the product from the current label.
What the method has to prove
- Specificity against the API and against the other panel members, demonstrated at the specification level and not only at the top of the range.
- Limit of quantitation at or below the working target, with the blank contribution subtracted and the residual blank reported.
- Accuracy and precision across the intended range, spiked into the actual matrix.
- Carry-over below the limit of quantitation after the highest standard.
- Solution stability, because these analytes are volatile and the autosampler is a good place to lose them.
Method development for nitrosamines rewards preparation over optimisation. Get the retention chemistry right, match the internal standard, then spend the remaining effort on the blank — that is where the sensitivity actually comes from.